Global Transfection Technologies Market Size By Transfection Method (Reagent-based Method, Instrument-based Method), By Applications (Biomedical Research, Therapeutic Delivery), By Geographic Scope And Forecast

Transfection Technologies Market Size And Forecast

Transfection Technologies Market size was valued at USD 1077.18 Million in 2022 and is projected to reach USD 2068.81 Million by 2030, growing at a CAGR of 8.50% from 2023 to 2030.

The market for transfection technologies will continue growing as a result of an increase in cell-based therapy research and development as well as an increase in cancer incidence. As the prevalence of cancer and the number of obese people rise, so does the demand for transfection. This factor is driving the Transfection Technologies Market. Furthermore, initiatives launched by various government agencies amplify market growth. The Global Transfection Technologies Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Transfection Technologies Market Definition

Transfection is a modern and effective method for introducing foreign nucleic acids into eukaryotic cells. The ability to modify the genetic content of host cells allows this process to be used to study normal cellular processes, disease molecular mechanisms, and gene therapeutic effects. Transfection technology inserts nucleic acids such as Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA), and oligonucleotides into cells. It is introduced using a variety of physical, chemical, and biological methods that can aid in the modification of specific cell properties.

Methods used include cotransfection, electroporation, cationic lipid transfection, and in-vivo transfection. This method is widely used in genomic studies such as gene expression, screening, RNA interference, and Vivo research, as well as virus and protein bioproduction. The two main goals of transfection are to produce recombinant proteins or to specifically enhance or inhibit gene expression in transfected cells. As such, transfection is a powerful analytical tool for studying the function and regulation of genes or gene products, producing transgenic organisms, and as a method for gene therapy.

Global Transfection Technologies Market Overview

The market for transfection technologies is expected to expand in the coming years. Transfection technology incorporates nucleic acids into cells, such as Deoxyribonucleic Acid  (DNA), oligonucleotides, and Ribonucleic Acid (RNA). It is introduced through a variety of physical, chemical, and biological methods that can aid in the modification of specific cell properties. Methods used include cotransfection, electroporation, cationic lipid transfection, and in-vivo transfection. This method is commonly used in genomic studies such as gene expression, screening, RNA interference, and Vivo research, as well as virus and protein bioproduction.

As more users are academic institutions and researchers, cell research is a major driving factor for the Transfection Technologies Market. In-vivo gene transfer research is being conducted for various therapeutic applications, and there is a growing demand for new transfection technologies to address unmet therapeutic delivery needs, which is driving the Transfection Technologies Market. Because of the lower cost and simpler methods involved in transfection, reagent-based transfection technology has seen an increase in demand.

Asia is home to a large number of emerging economies that are undergoing rapid changes in urbanization and healthcare facilities. The region is on its way to becoming one of the major players in the global pharmaceutical market, and current government funding will increase demand for transfection technologies as organizations work to innovate in the Transfection Technologies Market. However, the high cost of transfection technology instruments and home-brew reagents are major impediments. During the forecast period, they will pose additional challenges to the growth of the Transfection Technologies Market.

Global Transfection Technologies Market Segmentation Analysis

The Global Transfection Technologies Market is Segmented on the basis of Transfection Method, Applications, And Geography.

Transfection Technologies Market, By Transfection Method

• Reagent-based Method
• Instrument-based Method
• Virus-Based Method

Based on Transfection Method, the market is segmented into Reagent-based Method, Instrument-based Method, and Virus-Based Method. The reagent-based method has seen an increase in demand due to its cost-effectiveness and less complicated methods of transfection. This is due to a large number of launches by key players looking to expand their reagents portfolio. Aside from the routine use of reagents and kits across experimental protocols, companies offering reagents at a low cost are expected to drive the market for transfection reagents and equipment. The instrument-based method segment, on the other hand, is expected to grow rapidly during the forecast period. This is because cell systems that enable simple and cost-effective transient transfection while maintaining performance efficiency and primary cell compatibility have been developed. Researchers are using these systems on a large scale for various biotherapeutic and drug development activities.

Transfection Technologies Market, By Application

• Biomedical Research
• Therapeutic Delivery
• Protein Production

Based on the Application, the market is segmented into Biomedical Research, Therapeutic Delivery, and Protein Production. Biomedical research is expected to grow rapidly in the market for transfection technology during the forecast period. Transfection with lentivirus has gotten a lot of attention in biomedical research in recent years. Management of mutational analysis and library screening has biomedical research potential. As a result, the growing demand for exogenous gene transfection in various cell types and specific plasmids for library screening drives the use of these reagents and systems in biomedical research.

Transfection Technologies Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Based on Regional Analysis, the Transfection Technologies Market is classified into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America had the highest revenue share in the Transfection Technologies Market. This trend is anticipated to continue for the duration of the forecast period.  This is due to the presence of well-established manufacturers as well as substantial funding to promote cancer therapeutics, precision medicine, and advanced cytological studies.

The region’s additional market potential can supplement key market participants’ revenue in the Transfection Technologies Market in the United States. According to the American Cancer Society, there will be 1.9 million new cancer cases in the United States in 2021, with 608,570 cancer deaths. Because there are an increasing number of people suffering from chronic diseases such as cancer, there will be more research into treatments for these diseases, which is thought to be beneficial.

Key Players

The “Global Transfection Technologies Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Thermo Fisher Scientific, Sigma Aldrich, Promega Corporation, Lonza, Roche, Qiagen, Polyplus Transfection, Maxcyte, Mirius Bio, Altogen Biosystem. And among others.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In September 2022, Polyplus, a leading provider of upstream solutions for advanced biologic, cell, and gene therapy production from research to commercial grade is expanding its mRNA support portfolio. The in vivo-jetRNA+ transfection reagent for in vivo mRNA delivery using a preformed liposome has been released by the team.
• In August 2021, Mirus Bio, a pioneer in transfection technologies, introduced viral vector transfection kits for cell and gene therapy manufacturing. According to the company, transfection reagents were developed to improve the delivery of packaging and vector DNA to suspension in order to increase the production of recombinant adeno-associated virus (AAV) and lentivirus (LV) vectors.
• In August 2021, Polyplus released a transfection reagent for the large-scale production of viral vectors. Because of the increasing demand for viral vector production, Polyplus’s new launch has the potential to significantly ease the process of producing viral vectors.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Transfection Technologies Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. The porter’s five forces model can be used to assess the competitive landscape in Global Transfection Technologies Market gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product